The global landscape of cerebrovascular epidemiology is undergoing a significant transformation. For decades, international registries relied on traditional World Health Organization criteria that categorized stroke by a 24-hour symptom duration. However, the formal rollout of the International Classification of Diseases 11th Revision (ICD-11) officially establishes a tissue-based stroke definition. Under this modernized diagnostic paradigm, acute focal neurological deficits resolving within 24 hours qualify as ischemic stroke when neuroimaging confirms acute cerebral infarction. Consequently, clinicians, epidemiologists, and healthcare systems must now understand how this reclassification impacts disease incidence, survival rates, and service planning.

Transitioning to a Tissue-Based Stroke Definition in Modern Practice

Historically, the arbitrary 24-hour threshold separated transient ischemic attacks from true cerebral infarctions. Consequently, patients with quickly resolving symptoms were often classified as having experienced benign events, even when brain tissue sustained permanent injury. Diffusion-weighted magnetic resonance imaging fundamentally changed this perception. Modern neuroimaging rapidly detects acute cerebral ischemia within minutes of onset, proving that tissue injury frequently persists despite clinical recovery.

Therefore, the World Health Organization and stroke societies shifted toward objective biological markers of infarction. In ICD-11, any focal neurological deficit accompanied by neuroimaging evidence of ischemic damage represents an ischemic stroke. Although this transition aligns diagnosis with underlying neuropathology, it complicates comparisons with historical datasets. Specifically, clinicians must recognize that rising stroke rates reflect superior imaging sensitivity rather than a sudden epidemic.

Key Findings from the Normandy Stroke Population-Based Study

To assess the real-world consequences of this diagnostic shift, researchers conducted the Normandy Stroke Study in France. This comprehensive population-based registry analyzed 3,826 first-ever strokes diagnosed between May 2017 and December 2022. By utilizing multiple overlapping data sources, investigators ensured complete case ascertainment across hospital and outpatient settings.

Among patients fulfilling the tissue-based criteria, the median age was 76 years, and women represented 50.5% of cases. The age-standardized incidence rate was 161 per 100,000 person-years. Crucially, transitioning from a time-based definition to a tissue-based framework increased overall stroke incidence by 6.5%. Simultaneously, this shift reduced observed three-year stroke mortality by 3.9%, establishing a three-year mortality rate of 36.4%. Therefore, including transient events with neuroimaging lesions expands the stroke registry to encompass milder cases with better survival trajectories.

Disproportionate Impact on Younger Cohorts and Working-Age Adults

Importantly, the Normandy Stroke Study revealed that diagnostic reclassification affects demographic groups unevenly. The authors observed marked age-dependent differences across the study population. Among patients younger than 55 years, the tissue-based framework increased overall stroke incidence by 8.5%. In contrast, it increased incidence by 6.0% in patients aged 55 and older.

Furthermore, this difference was even more dramatic for acute ischemic stroke. In individuals under 55 years, tissue-based criteria increased ischemic stroke incidence by 12.5%, whereas the increase was only 7.3% in older adults. Younger patients presenting with focal neurological deficits frequently receive rapid emergency MRI evaluations. Because younger individuals often experience smaller embolic lesions that resolve quickly, their events were historically classified as transient ischemic attacks. Today, sensitive neuroimaging confirms infarction, substantially elevating documented stroke incidence in working-age cohorts.

Survival Metrics and Epidemiological Implications for Public Health

The shift toward tissue-based criteria also alters long-term post-stroke survival metrics. In the French cohort, recorded three-year mortality fell from 40.3% under the time-based definition to 36.4% under the tissue-based standard. Consequently, this apparent improvement represents an epidemiological artifact known as stage migration or the Will Rogers phenomenon.

By including patients who experience brief symptoms but show positive neuroimaging, researchers dilute overall cohort severity. Because these reclassified patients face much lower mortality risks than individuals with persistent neurological deficits, cumulative survival curves look artificially superior. However, physicians must avoid clinical complacency. Although these patients recover quickly from their initial symptoms, they face equivalent secondary vascular risks and recurrence rates. Therefore, healthcare registries must calibrate historical baselines when assessing modern stroke outcomes and quality benchmarks.

Clinical Considerations for Indian Healthcare Systems and Resource Allocation

These findings offer critical insights for healthcare delivery in developing countries like India. Currently, India carries a high cerebrovascular disease burden with early onset among young breadwinners. However, major resource disparities exist between urban tertiary centers and rural primary hospitals regarding diagnostic imaging infrastructure.

In metropolitan tertiary hospitals across India, magnetic resonance imaging is readily accessible, allowing rapid tissue-based diagnosis. Conversely, rural healthcare facilities rely primarily on non-contrast computed tomography, which often misses small ischemic lesions. Consequently, patients with identical presentations may receive a diagnosis of transient ischemic attack in rural clinics but acute stroke in corporate hospitals. Therefore, national stroke surveillance programs in India must account for imaging disparities. Furthermore, broadening MRI accessibility will ensure that younger Indian patients receive prompt secondary prevention and lifestyle interventions.

Harmonizing Surveillance Protocols During the Global Rollout of ICD-11

As nations gradually implement ICD-11, public health leaders must anticipate artificial shifts in surveillance data. The new framework integrates neuroimaging evidence of infarction. Consequently, national registries will inevitably report an apparent surge in stroke incidence, particularly in young adults. Without proper context, policymakers might erroneously conclude that primary prevention initiatives are failing.

Similarly, international authorities could misinterpret lower case fatality rates as major clinical triumphs rather than diagnostic artifacts. To prevent misleading conclusions, registries should concurrently report both time-based and tissue-based statistics during the multi-year implementation phase. In addition, health economists must update disability projections. Reclassified patients still require long-term secondary prophylaxis despite minor initial deficits. Ultimately, standardized surveillance ensures that healthcare resources and preventive medications are distributed equitably.

Frequently Asked Questions

How does ICD-11 define an acute ischemic stroke compared to older definitions?

The ICD-11 system incorporates a tissue-based standard, classifying any acute focal neurological deficit as an ischemic stroke if neuroimaging confirms infarction, regardless of duration. In contrast, older ICD-10 criteria relied on symptom duration, requiring neurological deficits to persist for at least 24 hours unless interrupted by early death.

Why does the tissue-based definition have a larger impact on younger stroke patients?

Younger patients often seek immediate emergency medical evaluation and undergo rapid diffusion-weighted magnetic resonance imaging. Furthermore, younger adults frequently experience small embolic or lacunar infarctions with neurological symptoms that resolve within 24 hours. Under time-based definitions, these were considered transient ischemic attacks rather than confirmed ischemic strokes.

Does the decrease in three-year mortality signify improved clinical stroke outcomes?

Not necessarily, because the lower mortality rate primarily reflects diagnostic stage migration rather than superior treatment. By reclassifying transient events with positive imaging as strokes, registries incorporate milder cases with inherently favorable survival prospects. Consequently, overall survival percentages improve artificially while individual disease biology remains unchanged.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Nehme A et al. Incidence and Post-Stroke Survival in the Normandy Stroke Population-Based Study (2017-2022): Impact of Time-Based Versus Tissue-Based Definitions. Neurology. 2026 Nov 10. doi: 10.1212/WNL.0000000000218457. PMID: 42886872.


2. Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064-2089.


3. Schneckenburger R, Boulanger M, Nehme A, et al. Epidemiology of transient ischemic attack in the Normandy Stroke population-based study. Eur Stroke J. 2024;9(4):948-956.